US equities |
MU $878.84 ▼-5.63% NVDA $214.13 ▼-1.43% TSLA $354.72 ▼-2.13% AAPL $343.46 ▲+0.43% META $709.33 ▼-3.72% MSFT $529.05 ▼-1.93% SPCX $146.03 ▼-1.74% AMD $528.75 ▼-5.95%
FinancialContent

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

6.790 -0.280 (-3.96%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into Maravai LifeSciences Holdings, Inc. (MRVI) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Earnings Scheduled For February 25, 2025 ↗
 
Via Benzinga
News headline image
4 Analysts Have This To Say About Maravai LifeSciences ↗
 
Via Benzinga
News headline image
Decoding 5 Analyst Evaluations For Maravai LifeSciences ↗
 
Via Benzinga
News headline image
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
From TriLink BioTechnologies
Via Business Wire
News headline image
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
From TriLink BioTechnologies
Via Business Wire
News headline image
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
Maravai LifeSciences Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗
 
Via Benzinga
News headline image
Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings ↗
 
Via Benzinga
News headline image
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
Announces Earnings Release Date 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Carl Hull to Retire as Executive Chairman 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Unveiling 4 Analyst Insights On Maravai LifeSciences ↗
 
Via Benzinga
News headline image
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday ↗
 
Via Benzinga
News headline image
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript ↗
MRVI earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
From TriLink BioTechnologies
Via Business Wire
News headline image
Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits
From TriLink BioTechnologies
Via Business Wire
News headline image
Wall Street Ticks Up As Consumer Sentiment Improves; Gold Hits Record Highs, Boosting Mining Stocks: What's Driving Markets Friday? ↗
Wall Street edged slightly higher on Friday, with major equity indices showing modest gains at midday in New York. 
Via Benzinga
News headline image
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript ↗
MRVI earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Maravai LifeSciences Reports Second Quarter 2024 Financial Results
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >